Wang S, Liu Y, Zhao X, Wang X, et al. RUNX1::ETO and CBFbeta::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia. Br J Haematol 2024;205:552-567.
PMID: 38802066